A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C

Clinical trial NCT01674725 · COMPLETED

Trial details

NCT number: NCT01674725
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis C Infection

Start date: 2012-08-01
Primary completion: 2014-01-01
Enrollment: 187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.